Answers are grounded in this paper and cite their sources.
Growing demand for minimally processed and clean-label foods has increased interest in lactic acid bacteria (LAB) as natural biopreservative agents. LAB produces diverse antimicrobial metabolites, including organic acids, bacteriocins, hydrogen peroxide, reuterin, reutericyclin, and antifungal compounds, which inhibit foodborne pathogens and spoilage microorganisms through distinct and potentially complementary mechanisms. This review critically examines the metabolic basis and mechanisms of LAB-derived antimicrobials and the factors governing their translation into effective food biopreservation. Particular emphasis is placed on the discrepancy between antimicrobial activity observed in vitro and efficacy in complex food matrices, where pH, proteins, lipids, water activity, temperature, food structure, and indigenous microbiota can substantially influence antimicrobial stability, bioavailability, and target-cell susceptibility. Microbial adaptation presents an additional challenge, as repeated or sublethal bacteriocin exposure can promote receptor modification, cell-envelope remodeling, metabolic adaptation, and reduced susceptibility or resistance. These findings demonstrate that antimicrobial production alone does not predict preservation efficacy. Future research should integrate quantitative metabolite characterization, food-matrix validation, and resistance assessment to identify mechanistically complementary antimicrobial combinations. Such approaches could shift LAB biopreservation from empirical antimicrobial screening toward more predictable, effective, and durable multi-hurdle preservation strategies.
No takes yet. Share an insight, caveat, or question.
Kapil Singh Narayan (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: